The K and BUP trials are within the stage 2 boundaries and are thus part of a phase 2 trial to consider dosing ranges, safety at those ranges and efficacy. Anything done at that point is setting the stage for a Phase 3 trial design. Hence, phase 2 is mid-stage, comes after phase 1 and before a final phase 3.